References
- Delliere S, Guery R, Candon S, et al. Understanding pathogenesis and care challenges of immune reconstitution inflammatory syndrome in fungal infections. J Fungi (Basel). 2018;4(4):pii: E139.
- O'Reilly MA, Govender D, Kirkwood AA, et al. The incidence of invasive fungal infections in children, adolescents and young adults with acute lymphoblastic leukaemia/lymphoma treated with the UKALL2011 protocol: a multicentre retrospective study. Br J Haematol. 2019;186(2):327–329.
- Koehler P, Hamprecht A, Bader O, et al. Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA Study. Int J Antimicrob Agents. 2017;49(2):218–223.
- Sallah S, Semelka RC, Wehbie R, et al. Hepatosplenic candidiasis in patients with acute leukaemia. Br J Haematol. 1999;106(3):697–701.
- Chaussade H, Bastides F, Lissandre S, et al. Usefulness of corticosteroid therapy during chronic disseminated candidiasis: case reports and literature review. J Antimicrob Chemother. 2012;67(6):1493–1495.
- Lionakis MS, Kontoyiannis DP. Glucocorticoids and invasive fungal infections. Lancet. 2003;362(9398):1828–1838.
- Limper AH. The changing spectrum of fungal infections in pulmonary and critical care practice: clinical approach to diagnosis. Proc Am Thorac Soc. 2010;7(3):163–168.
- Conter C, Dupont B, Thiesse P, et al. Persistent fever and hepatosplenic candidiasis, efficiency of a corticoid therapy. J Mycol Med. 2007;17(3):194–197.
- Legrand F, Lecuit M, Dupont B, et al. Adjuvant corticosteroid therapy for chronic disseminated candidiasis. Clin Infect Dis. 2008;46(5):696–702.
- Saint-Faust M, Boyer C, Gari-Toussaint M, et al. Adjuvant corticosteroid therapy in 2 children with hepatosplenic Candidiasis-related IRIS. J Pediat Hematol Onc. 2009;31(10):794–796.
- Chandesris MO, Kelaidi C, Mechai F, et al. Granulocyte colony stimulating Factor-induced exacerbation of Fungus-related immune restoration inflammatory syndrome: a case of chronic disseminated candidiasis exacerbation. J Microbiol Immunol. 2010;43(4):339–343.
- Bayram C, Fettah A, Yarali N, et al. Adjuvant corticosteroid therapy in hepatosplenic candidiasis-related iris. Mediterr J Hematol Infect Dis. 2012;4(1):e2012018.
- Zajac-Spychala O, Ukielska B, Jonczyk-Potoczna K, et al. Chronic disseminated candidiasis complicated by immune reconstitution inflammatory syndrome in child with acute lymphoblastic leukemia. Case Rep Hematol. 2016;2016:5960150.
- Shkalim-Zemer V, Levi I, Fischer S, et al. Response of symptomatic persistent chronic disseminated candidiasis to corticosteroid therapy in immunosuppressed pediatric patients: case study and review of the literature. Pediatr Infect Dis J. 2018;37(7):686–690.
- Yamazaki-Nakashimada MA, Stiehm ER, Pietropaolo-Cienfuegos D, et al. Corticosteroid therapy for refractory infections in chronic granulomatous disease: case reports and review of the literature. Ann Allergy Asthma Immunol. 2006;97(2):257–261.
- Magnani A, Brosselin P, Beaute J, et al. Inflammatory manifestations in a single-center cohort of patients with chronic granulomatous disease. J Allergy Clin Immunol. 2014;134(3):655–662.e8.